BC
AMGN icon

Barnett & Company’s Amgen AMGN Stock Holding History

Barnett & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12
Closed -$3K – 103
2021
Q4 		$3K Buy
+12
New +$2.53K ﹤0.01% 252
2020
Q2 		– Sell
-189
Closed -$38K – 289
2020
Q1 		$38K Sell
189
-4
-2% -$874 0.04% 146
2019
Q4 		$47K Buy
193
+189
+4,725% +$41.7K 0.03% 171
2019
Q3 		$1K Buy
+4
New +$768 ﹤0.01% 339

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barnett & Company's AMGN Position: Q1 2022 in Review

Barnett & Company sold out of Amgen (AMGN) in Q1 2022, closing a stake of 12 shares — an estimated $3K sold.

Barnett & Company first reported a position in AMGN in Q3 2019 and held it in 4 quarters. The position peaked at $47K in Q4 2019. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Barnett & Company reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Barnett & Company sold 12 Amgen shares in Q1 2022, an estimated $3K.
  • Barnett & Company first reported a position in Amgen in Q3 2019 and held it in 4 quarters.
  • Barnett & Company's Amgen position peaked at $47K in Q4 2019.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.